%0 Journal Article %A Caleb Alexander, G. %A Ogasawara, Ken %A Wiegand, Dana %A Lin, Dora %A Breder, Christopher D. %D 2018 %T Supplemental Material, 812058_web_appendix - Clinical Development of Biologics Approved by the US Food and Drug Administration, 2003-2016 %U https://sage.figshare.com/articles/journal_contribution/Supplemental_Material_812058_web_appendix_-_Clinical_Development_of_Biologics_Approved_by_the_US_Food_and_Drug_Administration_2003-2016/7441256 %R 10.25384/SAGE.7441256.v1 %2 https://sage.figshare.com/ndownloader/files/13773764 %K drug approval %K regulatory affairs %K expedited programs %X

Supplemental Material, 812058_web_appendix for Clinical Development of Biologics Approved by the US Food and Drug Administration, 2003-2016 by G. Caleb Alexander, Ken Ogasawara, Dana Wiegand, Dora Lin, and Christopher D. Breder in Therapeutic Innovation & Regulatory Science

%I SAGE Journals